mepivacaine

1
Reactions 1162 - 28 Jul 2007 Mepivacaine Urticaria and pruritus: case report A 39-year-old man developed pruritus and generalised urticaria after receiving mepivacaine as a local anaesthetic. He subsequently developed cross-reactivity to lidocaine and ropivacaine. The man received mepivacaine [Scandinibsa] [dosage not stated] during extirpation of a naevus; 15 minutes later, he developed pruritus and generalised urticaria. The urticaria was treated with oral corticosteroids and antihistamines, and resolved within a few hours. Three months later, the man attended an allergy unit in order to further investigate the adverse reaction. A prick test with 1% mepivacaine was positive (5mm). In response to an intradermal test with mepivacaine at a 1:100 dilution, he developed a wheal 12 × 15mm with pseudopodia, and an immediate urticarial reaction that spread along the thorax and forearm. This reaction was treated with antihistamines and subsided within an hour. In order to assess cross-reactivity with other amide-type local anaesthetics, prick tests were performed with an undiluted solution of each drug, and intradermal tests done at 1:100 dilution. Lidocaine yielded a positive prick test result of 5 × 4mm, and in response to the intradermal skin test, a 20 × 30mm wheal associated with an immediate local urticaria. Ropivacaine yielded a positive prick test result of 4 × 3mm, and in response to the intradermal skin test, a wheal of 10 × 8mm. Gonz´ alez-Delgado P, et al. Cross-reactivity among amide-type local anesthetics in a case of allergy to mepivacaine. Journal of Investigational Allergology and Clinical Immunology 16: 311-313, No. 5, 2006 - Spain 801078933 1 Reactions 28 Jul 2007 No. 1162 0114-9954/10/1162-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Upload: lymien

Post on 20-Mar-2017

214 views

Category:

Documents


0 download

TRANSCRIPT

Reactions 1162 - 28 Jul 2007

Mepivacaine

Urticaria and pruritus: case reportA 39-year-old man developed pruritus and generalised

urticaria after receiving mepivacaine as a local anaesthetic. Hesubsequently developed cross-reactivity to lidocaine andropivacaine.

The man received mepivacaine [Scandinibsa] [dosage notstated] during extirpation of a naevus; 15 minutes later, hedeveloped pruritus and generalised urticaria.

The urticaria was treated with oral corticosteroids andantihistamines, and resolved within a few hours.

Three months later, the man attended an allergy unit inorder to further investigate the adverse reaction. A prick testwith 1% mepivacaine was positive (5mm). In response to anintradermal test with mepivacaine at a 1:100 dilution, hedeveloped a wheal 12 × 15mm with pseudopodia, and animmediate urticarial reaction that spread along the thorax andforearm. This reaction was treated with antihistamines andsubsided within an hour. In order to assess cross-reactivitywith other amide-type local anaesthetics, prick tests wereperformed with an undiluted solution of each drug, andintradermal tests done at 1:100 dilution. Lidocaine yielded apositive prick test result of 5 × 4mm, and in response to theintradermal skin test, a 20 × 30mm wheal associated with animmediate local urticaria. Ropivacaine yielded a positive pricktest result of 4 × 3mm, and in response to the intradermal skintest, a wheal of 10 × 8mm.Gonzalez-Delgado P, et al. Cross-reactivity among amide-type local anesthetics ina case of allergy to mepivacaine. Journal of Investigational Allergology andClinical Immunology 16: 311-313, No. 5, 2006 - Spain 801078933

1

Reactions 28 Jul 2007 No. 11620114-9954/10/1162-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved